 |
Human Clinical Study! Next generation dual action carb blocker! Reduces glycemic index of foods! |
InSea²™ is the only product on the market today that exhibits a dual mechanism of action against the two digestive enzymes involved in the digestion and assimilation of carbohydrates ingested during a meal (amylase and sucrase). From natural origin, InSea²™ is an optimized blend of polyphenols derived from two species of brown seaweeds. In clinical study, InSea²™ significantly decreased blood glucose and insulin responses that follow a high carbohydrate meal, and improved insulin sensitivity. InSea²™ may thus be used in formulations of natural health products aiming at reducing the glycemic index of foods.
Results from this clinical trial were recently presented at the international Experimental Biology meeting and were submitted for publication in a peer-reviewed medical journal.
InSea2™ is offered from our partners in the following territories:
United States of America:
651-245-8733
scott@nutrabridge.com
Brasil:
Idealfarma
55 62 3316.3530
adm@idealfarma.com.br
Indonesia:
PT Demka Sakti
Melinda Widjaja
Tél: 62-21-3453422
miwidjaja@demkasakti.com
Thailand:
Berli Jucker Public Company Ltd.
(66)0-2367-1781
umapornb@bjc.co.th
Feel free to contact us for additional information on InSea²™.
is present in the following products:
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
